NEWLY DIAGNOSED
Clinical trials for NEWLY DIAGNOSED explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to delay ovarian Cancer's return in High-Risk patients
Disease control OngoingThis large, late-stage trial is testing whether a drug called olaparib can help keep advanced ovarian cancer from coming back after initial chemotherapy. It is for women with a specific genetic change (BRCA mutation) whose cancer responded well to first treatment. The study compa…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug combo tested for deadly brain cancer
Disease control OngoingThis early-stage trial is testing whether adding an experimental drug called selinexor to standard radiation and chemotherapy is safe for people with newly diagnosed glioblastoma, an aggressive brain cancer. Researchers want to find the highest dose of selinexor that patients can…
Matched conditions: NEWLY DIAGNOSED
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC